tradingkey.logo

tradingkey.logo
怜玢


Sanofi SA

SNY
りォッチリストに远加
39.770USD
+0.650+1.66%
終倀 10-14 16:00ET
95.29B時䟡総額
11.06盎近12ヶ月PER
前堎取匕 06:14 (ET)40.680USD+0.910+2.29%

Sanofi SAに぀いお 䌁業名

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Sanofi SA プロフィヌル


䌁業コヌドSNY
䌚瀟名Sanofi SA
䞊堎日Jul 01, 2002
最高経営責任者「CEO」Hudson (Paul)
埓業員数84587
蚌刞皮類Depository Receipt
決算期末Jul 01
本瀟所圚地46 Avenue de la Grande Armee
郜垂PARIS
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜France
郵䟿番号75017
電話番号33153774000
りェブサむトhttps://www.sanofi.com/
䌁業コヌドSNY
䞊堎日Jul 01, 2002
最高経営責任者「CEO」Hudson (Paul)

Sanofi SAの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Olivier Charmeil
Mr. Olivier Charmeil
Executive Vice President - General Medicines, Member of the Executive Committee
Executive Vice President - General Medicines, Member of the Executive Committee
--
--
Dr. Belen Garijo, M.D.
Dr. Belen Garijo, M.D.
Chief Executive Officer, Member of the Executive Committee, Director
Chief Executive Officer, Member of the Executive Committee, Director
--
--
Ms. Fabienne Lecorvaisier
Ms. Fabienne Lecorvaisier
Independent Director
Independent Director
--
--
Mr. Patrick Kron
Mr. Patrick Kron
Independent Director
Independent Director
--
--
Mr. Christophe Babule
Mr. Christophe Babule
Director
Director
--
--
Mr. Paul Hudson, Ph.D.
Mr. Paul Hudson, Ph.D.
Chief Executive Officer, Executive Director, Member of the Executive Committee
Chief Executive Officer, Executive Director, Member of the Executive Committee
--
--
Ms. Rachel Duan
Ms. Rachel Duan
Independent Director
Independent Director
--
--
Ms. Lise Kingo
Ms. Lise Kingo
Independent Director
Independent Director
--
--
Ms. Natalie Bickford
Ms. Natalie Bickford
Chief People Officer, Executive Vice President, Member of the Executive Committee
Chief People Officer, Executive Vice President, Member of the Executive Committee
--
--
Ms. Julie Van Ongevalle
Ms. Julie Van Ongevalle
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Olivier Charmeil
Mr. Olivier Charmeil
Executive Vice President - General Medicines, Member of the Executive Committee
Executive Vice President - General Medicines, Member of the Executive Committee
--
--
Dr. Belen Garijo, M.D.
Dr. Belen Garijo, M.D.
Chief Executive Officer, Member of the Executive Committee, Director
Chief Executive Officer, Member of the Executive Committee, Director
--
--
Ms. Fabienne Lecorvaisier
Ms. Fabienne Lecorvaisier
Independent Director
Independent Director
--
--
Mr. Patrick Kron
Mr. Patrick Kron
Independent Director
Independent Director
--
--
Mr. Christophe Babule
Mr. Christophe Babule
Director
Director
--
--
Mr. Paul Hudson, Ph.D.
Mr. Paul Hudson, Ph.D.
Chief Executive Officer, Executive Director, Member of the Executive Committee
Chief Executive Officer, Executive Director, Member of the Executive Committee
--
--

よくある質問

Sanofi SAの䞊䜍5名の株䞻は誰ですか


Sanofi SAの䞊䜍5名の株䞻は以䞋のずおりです。Ms. Christel Heydemann

Sanofi SASNYの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Sanofi SAの株匏を保有しおいる機関は1330瀟あり、保有株匏の総垂堎䟡倀は玄225.52Mで、党䜓の9.34%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-36323619.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。